Abstract
Background The independent impact of HIV and bacterial vaginal colonization on pregnancy outcomes has been documented and is compounded by the burden of rapidly escalating antimicrobial resistance. However, the interactive effect of HIV and lower genital tract bacterial colonization, on pregnancy outcomes has not been thoroughly studied and is examined in our study.
Methods We performed a systematic review and meta-analysis to quantitatively assess the interaction between HIV and vaginal bacterial colonization and associations with birth weight and preterm birth. We searched Ovid MEDLINE, Ovid EMBASE, CINAHL, Scopus, Web of Science, Cochrane Library, African Journals Online, and PubMed databases to identify studies published up to December 31, 2023. We included observational reporting on vaginal colonization with bacterial pathogens stratified by HIV status that reported pregnancy outcomes. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and used a modified Newcastle-Ottawa Scale to assess study quality. Meta-analysis was conducted using random-effects modeling in STATA Version 18. Pooled log-odds ratios were calculated. The study protocol was registered in PROSPERO(CRD42023485123).
Results We selected 13 studies, involving 6,073 pregnant women, from 5,807 studies identified. The overall pooled prevalence of bacterial colonization was 26%(95%CI:17.3-37.4). There was no significant effect of HIV status and vaginal colonization on birth weight(OR=1.2, 95%CI:-2.57-2.20, p=0.88) and borderline increased odds of preterm birth (OR=2.64, 95%CI:-0.01-1.94, p=0.05). There was no significant association between HIV status and bacterial colonization(OR=1.08, 95%CI =-0.91-1.07), nor in antimicrobial resistance between pregnant women with HIV and those without.
Conclusion Bacterial colonization is prevalent among pregnant women, but there is no clear evidence to suggest that HIV and bacterial colonization interact to affect birth weight or preterm birth. Research with large sample sizes, strict selection criteria, reliable and valid measurement, adequate control for confounding variables, and birthweight and gestational age at delivery assessment as continuous outcomes are still needed to provide robust evidence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Study in Canada Scholarships (SiCS) grant and NIH-Fogarty International Center D43 Research Training Grant to CUHAS (D43 TW011826). The content is solely the authors' responsibility and does not necessarily reflect the official views of the NIH or SiCS.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Permission for publication was sought from the CUHAS/BMC Research & Ethical Committee (CREC).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The data analyzed during the current systematic review and meta-analysis are available and made public (S3 Appendix).
Abbreviations
- AMR
- Antimicrobial Resistance
- AMSTAR
- Assessing the Methodological Quality of Systematic Reviews
- ANC
- Antenatal Care
- CINAHL
- Cumulative Index to Nursing and Allied Health Literature
- CMA
- Comprehensive Meta-Analysis
- CI
- Confidence Interval
- HICs
- High-Income Countries
- HIV
- Immunodeficiency Virus
- IUGR
- Intrauterine Growth restrictions
- LBW
- Low Birth Weight
- LMICs
- Low-Middle Income Countries
- MESH
- Medical Subject Headings
- OR
- Odds ratio
- NIH
- National Institutes of Health
- NOS
- New Castle-Ottawa Scale
- PCR
- Polymerase Chain Reaction
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- SGA
- Small for Gestation
- SD
- Standard Deviation
- SSA
- Sub-Saharan Africa
